2006
DOI: 10.1016/j.tox.2005.09.013
|View full text |Cite
|
Sign up to set email alerts
|

TDI can induce respiratory allergy with Th2-dominated response in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
54
0

Year Published

2006
2006
2015
2015

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 69 publications
(56 citation statements)
references
References 36 publications
2
54
0
Order By: Relevance
“…Although AR, defined as an IgE-mediated disease, could be different from TDI-induced, non-IgE-mediated rhinitis, nasal allergic-like symptoms induced by TDI are similar to those observed in AR patients (38,39). Additionally, TDI-sensitized rats also display many of the characteristic features of AR in humans, including infiltration of eosinophils and mast cells (40), increase in the level of cytokines (8,(41)(42)(43), elevation of H1R mRNA and protein level (12), increase in the HDC mRNA level, HDC activity, and histamine content (13), even though histamine release was triggered by neuropeptide, but not IgE, in TDI-sensitized animals. Furthermore, the expression of IL-4 and IL-5 mRNAs was also up-regulated in the nasal mucosa of TDI-sensitized rats after provocation with TDI (16,17).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although AR, defined as an IgE-mediated disease, could be different from TDI-induced, non-IgE-mediated rhinitis, nasal allergic-like symptoms induced by TDI are similar to those observed in AR patients (38,39). Additionally, TDI-sensitized rats also display many of the characteristic features of AR in humans, including infiltration of eosinophils and mast cells (40), increase in the level of cytokines (8,(41)(42)(43), elevation of H1R mRNA and protein level (12), increase in the HDC mRNA level, HDC activity, and histamine content (13), even though histamine release was triggered by neuropeptide, but not IgE, in TDI-sensitized animals. Furthermore, the expression of IL-4 and IL-5 mRNAs was also up-regulated in the nasal mucosa of TDI-sensitized rats after provocation with TDI (16,17).…”
Section: Discussionmentioning
confidence: 99%
“…Toluene-2,4-diisocyanate (TDI), a highly reactive industrial chemical, is one of the leading causes of occupation-related asthma in industrialized countries (8). We demonstrated previously that repeated intranasal application of TDI induced release of histamine from mast cells via neurogenic inflammation and led to the development of nasal hypersensitivity in guinea pigs and rats (9 -11).…”
Section: A Llergic Rhinitis (Ar)mentioning
confidence: 99%
“…Topical application followed by intra-tracheal instillations of TDI resulted in local and systemic Th2-dominated immune responses associated with a rise in IL-4, IL-5 and IL-13. On the other hand, the experimental design, in which TDI was administrated by inhalation only, failed to provoke a vigorous Th2 immune response, with a slight increase in IL-5 production and serum total IgE [ 23]. However, other authors have observed the significant increase of Th2 cytokines after inhalation exposure of TDI.…”
Section: Ethicsmentioning
confidence: 95%
“…Numerous data are accessible from works considering the type of immune response and determinants in TDI-induced asthma. Ban et al [23] described four models of TDI-induced asthma, where the immune-mediated mechanisms depended on the route of administration. Topical application followed by intra-tracheal instillations of TDI resulted in local and systemic Th2-dominated immune responses associated with a rise in IL-4, IL-5 and IL-13.…”
Section: Ethicsmentioning
confidence: 99%
“…Therefore, we chose to test PPD and PTD in an exposure regimen in BALB/c mice where the antigen-specific hypersensitivity response to the contact allergens 2,4-dinitrofluorobenzene (DNFB) and toluene 2,4-diisocyanate (TDI) was T H 2-like upon five repeated topical applications within 12 or 28 days (Dearman et al, 1996;Nagai et al, 1997;Warbrick et al, 1998). The respiratory sensitizer TDI was only used as a positive control since both T H 1 and T H 2 responses can be generated to this chemical in animal models (Matheson et al, 2005;Ban et al, 2006) and in man (Liippo and Lammintausta, 2008). The study was not designed to compare potencies of PPD or PTD to TDI or to each other.…”
Section: R E S E a R C H A R T I C L Ementioning
confidence: 99%